William E Copeland

6PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 12, 2026
CIZ1 regulates G1 length and the CDK threshold for initiation of DNA replication to prevent DNA replication stress.

|Aug 27, 2026
Correction: Pauzaite et al. Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. Biomedicines 2022, 10, 2012.

|Sep 15, 2025
DNA Methylation Signatures of Alcohol Use Disorder - A large-scale Meta-Analysis in the Psychiatric Genomics Consortium.

Lea Zillich, Sofia D'Augello, Diana Avetyan

|Aug 26, 2022
Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway.

Tekle Pauzaite, James Tollitt, Betul Sopaci

|Jun 24, 2022
Light-responsive biomaterials for ocular drug delivery.

Hend A M Abdelmohsen, Nikki A Copeland, John G Hardy

|Jan 12, 2021
Detection of CRISPR-Cas9-Mediated Mutations Using a Carbon Nanotube-Modified Electrochemical Genosensor.

Ezgi Kivrak, Tekle Pauzaite, Nikki A Copeland

Pageof 1

Frequent Collaborators

4 joint publications

John G Hardy

2 joint publications

Tekle Pauzaite

2 joint publications

Sarah L Allinson

1 joint publications

Ezgi Kivrak